» Articles » PMID: 20026567

Brief Report: Barriers to Treatment Adherence in Pediatric Inflammatory Bowel Disease

Overview
Date 2009 Dec 23
PMID 20026567
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine perceived barriers to medication adherence in inflammatory bowel disease (IBD) treatment and their relationship with adherence using a combined forced choice and semi-structured interview assessment approach.

Methods: Sixteen adolescents with IBD and their parents participated in an open-ended interview regarding adherence barriers and completed quantitative measures of adherence, barriers to treatment, and disease severity.

Results: The most commonly identified barriers to adherence were forgetting, interference with other activities, difficulty swallowing pills, and not being at home. Number of reported barriers was positively correlated with objective nonadherence for 6-MP/azathioprine. Nonadherence frequency was 42% for 6-MP/azathoprine and 50% for 5-ASA medications.

Conclusions: Using a combined assessment approach, patients and parents reported several barriers to treatment adherence that are appropriate for clinical intervention. This is critical given the significant medication nonadherence observed in this sample and the relationship between total number of barriers and disease management problems.

Citing Articles

Self-Management assistance for recommended treatment (SMART) IBD app randomized control trial in adolescents with IBD: Design and methodology.

Roberts C, Plevinsky J, Gamwell K, Noser A, Denson L, Hommel K Health Care Transit. 2024; 2:100031.

PMID: 39712584 PMC: 11657775. DOI: 10.1016/j.hctj.2023.100031.


A Self-led Self-management Intervention Supporting Teens with IBD (ASSIST-IBD): protocol for a feasibility study of a novel digital treatment adherence intervention.

Screti C, Atkinson L, Shaw R, Muhammed R, Heath G BMJ Open. 2024; 14(10):e085576.

PMID: 39414300 PMC: 11487816. DOI: 10.1136/bmjopen-2024-085576.


A qualitative evaluation of treatment fidelity alongside a pilot trial of a novel therapy for pediatric Inflammatory Bowel Disease.

Olson J, Castillo G, Palumbo A, Harrison M, Singleton R, Lalu M PLoS One. 2024; 19(7):e0292709.

PMID: 39078826 PMC: 11288461. DOI: 10.1371/journal.pone.0292709.


Demystifying a family-based epilepsy adherence problem-solving intervention: Exploring adherence barriers and solutions.

Williford D, Guilfoyle S, Modi A Clin Pract Pediatr Psychol. 2023; 11(1):66-73.

PMID: 36969546 PMC: 10038204. DOI: 10.1037/cpp0000436.


Barriers to medication adherence among adolescents and young adults with cancer.

McGrady M, Ketterl T, Norris R, Perentesis J, Pettee D, Mara C Pediatr Blood Cancer. 2023; 70(3):e30186.

PMID: 36602026 PMC: 11587192. DOI: 10.1002/pbc.30186.


References
1.
Oliva-Hemker M, Abadom V, Cuffari C, Thompson R . Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2007; 44(2):180-4. DOI: 10.1097/MPG.0b013e31802b320e. View

2.
Lichtiger S, Present D, Kornbluth A, Gelernt I, Bauer J, Galler G . Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994; 330(26):1841-5. DOI: 10.1056/NEJM199406303302601. View

3.
Logan D, Zelikovsky N, Labay L, Spergel J . The Illness Management Survey: identifying adolescents' perceptions of barriers to adherence. J Pediatr Psychol. 2003; 28(6):383-92. DOI: 10.1093/jpepsy/jsg028. View

4.
Zelikovsky N, Schast A . Eliciting accurate reports of adherence in a clinical interview: development of the Medical Adherence Measure. Pediatr Nurs. 2008; 34(2):141-6. View

5.
Simons L, Blount R . Identifying barriers to medication adherence in adolescent transplant recipients. J Pediatr Psychol. 2007; 32(7):831-44. DOI: 10.1093/jpepsy/jsm030. View